Bayer AG
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast age… Read more
Bayer AG (BAYZF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.156x
Based on the latest financial reports, Bayer AG (BAYZF) has a cash flow conversion efficiency ratio of 0.156x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.00 Billion) by net assets ($32.05 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bayer AG - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Bayer AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bayer AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bayer AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oriental Land Co. Ltd
PINK:OLCLF
|
0.022x |
|
Telefonaktiebolaget LM Ericsson Class B
PINK:ERIXF
|
0.150x |
|
Constellation Brands Inc Class A
NYSE:STZ
|
0.077x |
|
AIB Group plc
PINK:AIBGY
|
0.069x |
|
Heidelberg Materials AG
XETRA:HEI
|
0.003x |
|
Ares Management LP
NYSE:ARES
|
0.156x |
|
Accton Technology Corp
TW:2345
|
0.377x |
|
Williams-Sonoma Inc
NYSE:WSM
|
0.154x |
Annual Cash Flow Conversion Efficiency for Bayer AG (2004–2024)
The table below shows the annual cash flow conversion efficiency of Bayer AG from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $32.05 Billion | $7.37 Billion | 0.230x | +48.63% |
| 2023-12-31 | $33.08 Billion | $5.12 Billion | 0.155x | -15.10% |
| 2022-12-31 | $38.93 Billion | $7.09 Billion | 0.182x | +18.76% |
| 2021-12-31 | $33.17 Billion | $5.09 Billion | 0.153x | -3.93% |
| 2020-12-31 | $30.70 Billion | $4.90 Billion | 0.160x | -7.53% |
| 2019-12-31 | $47.52 Billion | $8.21 Billion | 0.173x | +0.68% |
| 2018-12-31 | $46.15 Billion | $7.92 Billion | 0.172x | -22.26% |
| 2017-12-31 | $36.86 Billion | $8.13 Billion | 0.221x | -22.56% |
| 2016-12-31 | $31.90 Billion | $9.09 Billion | 0.285x | +5.23% |
| 2015-12-31 | $25.45 Billion | $6.89 Billion | 0.271x | -5.77% |
| 2014-12-31 | $24.46 Billion | $7.03 Billion | 0.287x | +15.61% |
| 2013-12-31 | $20.80 Billion | $5.17 Billion | 0.249x | -27.96% |
| 2006-12-31 | $16.08 Billion | $5.55 Billion | 0.345x | +21.65% |
| 2005-12-31 | $14.62 Billion | $4.15 Billion | 0.284x | +51.04% |
| 2004-12-31 | $17.80 Billion | $3.34 Billion | 0.188x | -- |